Policy & Ethics
Today, ILSI, formerly known as the International Life Sciences Institute, announced it has rebranded. The effort includes a new logo, a refreshed visual identity and an updated website, which all reflect the organization’s evolution and its aspirations for the future.
A special issue of the American Journal of Psychiatry, released today at the American Psychiatric Association’s Annual Meeting, highlights the pervasive negative consequences of structural racism on mental health and the importance of community and system-wide interventions and proposes mental health inequity research priorities.
- American Journal of Psychiatry
- 2022 American Psychiatric Association Annual Meeting
Dr. Andrew Frazelle and his operations management colleagues proposed a novel contract that may help alleviate key sources of conflict between restaurants and food-delivery platforms.
- Management Science
The University of Minnesota has received $66 million from NIAID to establish a Midwest center to develop antiviral drugs for pandemic-level viruses, including SARS-CoV-2.
- NIH/National Institute of Allergy and Infectious Diseases
A Staffordshire University Professor has published an essential guide to help EFT practitioners share their experiences of how ‘tapping’ is being used to treat people around the world. Emotional Freedom Techniques (EFT) or ‘tapping’ is a combined somatic and cognitive therapy which thousands of therapists and practitioners worldwide have integrated into their practice. EFT is also a popular self-help technique, used by millions of people to relieve a variety of issues including aches and pains, stress and anxiety, fears and phobias, cravings and addictions, and much more.
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health awarded the UNC Gillings School of Global Public Health a $65 million grant establishing an Antiviral Drug Discovery Center to develop oral antivirals that can combat pandemic-level viruses like COVID-19. The center builds upon and is tightly affiliated with UNC’s Rapidly Emerging Antiviral Drug Development Initiative.